1994
DOI: 10.1016/0300-9572(94)90070-1
|View full text |Cite
|
Sign up to set email alerts
|

Comparison of adrenergic agonists for the treatment of ventricular fibrillation and pulseless electrical activity

Abstract: The primary role of epinephrine for the treatment of ventricular fibrillation (VF) and pulseless electrical activity (PEA) is to increase blood flow to the myocardium and central nervous system and ultimately improve survival. However, despite the administration of epinephrine, survival following VF or PEA is low. In an attempt to improve outcome from VF and PEA, alternative adrenergic agonists (methoxamine, phenylephrine, norepinephrine) which have different pharmacological properties than epinephrine have be… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

1996
1996
2015
2015

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 69 publications
0
1
0
Order By: Relevance
“…[ 22 ] Patients or animals who present with PEA or asystole typically have higher mortality rates and reduced chances of achieving ROSC. [ 23 24 25 26 ] During the untreated 8 min after CA, the electrocardiographs exhibited several changes, including VF, PEA, and asystole. Approximately, 50% of the animals in this study exhibited VF prior to CPR.…”
Section: Discussionmentioning
confidence: 99%
“…[ 22 ] Patients or animals who present with PEA or asystole typically have higher mortality rates and reduced chances of achieving ROSC. [ 23 24 25 26 ] During the untreated 8 min after CA, the electrocardiographs exhibited several changes, including VF, PEA, and asystole. Approximately, 50% of the animals in this study exhibited VF prior to CPR.…”
Section: Discussionmentioning
confidence: 99%